Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2021

Feb 19, 2021

30583_dirs_2021-02-19_8dc48266-ab43-44b3-a2bf-0c2b14d0aa5d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2021-02-17

Reporting Person: Ho Maykin (Director)

More from BIOMARIN PHARMACEUTICAL INC

Declaration of Voting Results & Voting Rights Announcements 2026
Jun 4
Interim / Quarterly Report 2026
May 5
Report Publication Announcement 2026
May 4
M&A Activity 2026
Apr 27
M&A Activity 2026
Apr 23
Annual Report 2026
Apr 21
Director's Dealing 2026
Mar 19
Director's Dealing 2026
Mar 19
Director's Dealing 2026
Mar 19
Director's Dealing 2026
Mar 19
View all filings →